Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.95 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.95 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.95 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | EYA2 | O00167 | 1/20 | 0.59 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | DRD1 | P21728 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Egtazic Acid SCHEMBL831877 | 1.00 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL456632 | 1.00 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL456238 | 1.00 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL920203 | 0.98 | BLM (1.00) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL11684972 | 0.98 | BLM (1.00) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL22901 | 0.98 | BLM (1.00) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL23859106 | 0.95 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL5067266 | 0.95 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL7541607 | 0.95 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL15413556 | 0.95 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0743519-B1 | Improved method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes | BAYER AG (US) | 2002-08-28 | — | — | EP | claimed |
| EP-4741492-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2026-05-13 | — | — | EP | disclosed |
| EP-4701625-A2 | FORMULATION OF THERAPEUTIC AGENTS FOR IMPROVED PERMEATION | Vivtex Corporation (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4648769-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2025-11-19 | — | — | EP | disclosed |
| CN-119015266-A | Water-soluble mixture and method for producing the same | 东莞市吉纯生物技术有限公司 | 2024-11-26 | — | — | CN | disclosed |
| WO-2024226846-A2 | FORMULATION OF THERAPEUTIC AGENTS FOR IMPROVED PERMEATION | VIVTEX CORPORATION (US) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024150130-A2 | NECROSIS INHIBITOR | LINKGEVITY LIMITED (GB) | 2024-07-18 | — | — | WO | disclosed |
| US-7741283-B2 | Compositions and methods for inhibiting cell proliferation | ST. LOUIS UNIVERSITY (US) | 2010-06-22 | — | — | US | disclosed |
| EP-1836323-A1 | METHOD OF PROTECTING AN ANIMAL SKIN PRODUCT FROM METALLOPROTEINASE ACTIVITY | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2007-09-26 | — | — | EP | disclosed |
| WO-2006060297-A1 | METHOD OF PROTECTING AN ANIMAL SKIN PRODUCT FROM METALLOPROTEINASE ACTIVITY | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2006-06-08 | — | — | WO | disclosed |
| US-20060112494-A1 | Method of protecting an animal skin product from metalloproteinase activity | BUCKMAN LABORATORIES INTERNATIONAL, INC. | 2006-06-01 | — | — | US | disclosed |
| US-20050250692-A1 | transforming growth factor and insulin like growth factor binding protein 3 as ligands that engage low density lipoprotein receptor-related protein | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-11-10 | — | — | US | disclosed |